First public hearings into New Zealand's Covid-19 response to begin
Photo:
RNZ
The first public hearings into New Zealand's Covid response get underway today - with a focus on lockdowns and vaccines.
The Royal Commission of Inquiry into Covid-19 is looking into the government's response to the pandemic and its effects.
It is the first time submissions will be heard publicly, with the sessions live-streamed.
This week's hearings particularly concentrate on the impact of the extended lockdown in Auckland and Northland in 2021 and on vaccine mandates and safety.
In a minute issued on the Inquiry's website chair Grant Illingworth KC said that would include the effect on "social division and isolation, health and education, and business activity.
"We will also hear from experts about the key decisions and their consequences, and lessons to be learned from what happened."
The hearings would be in secure hearing rooms, with commissioners, witnesses, lawyers and media present.
There was no provision for public attendance beyond those submitting but the live streams would run and be available as recordings as well, the minute said.
Witnesses would be questioned by lawyers helping the inquiry, and commissioners could ask questions.
A second public hearing was due next month in Wellington.
That was to hear from key decisions makers who "led and informed" the government's response to the pandemic.
This Royal Commission was set up under the previous Labour government, but its brief was expanded under the current government, with Illingworth taking the chairing role.
A report from the first phase was delivered last year.
Sign up for Ngā Pitopito Kōrero
,
a daily newsletter curated by our editors and delivered straight to your inbox every weekday.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
RNZ News
an hour ago
- RNZ News
Pharmac makes asthma inhalers, IUDs more accessible
Photo: 123RF Pharmac is making it easier for people to access asthma inhalers and IUD contraception - a move the minister says is sensible and costs no one. From 1 August, people using some strengths of budesonide with eformoterol inhalers for asthma will be available for a three-month prescription instead of just one. Mirena and Jaydess Intra-Uterine Devices (IUDs) - which can prevent pregnancy, including by administering hormones - will be able to be stored at doctors' surgeries. This means patients will not need to pick them up from a pharmacy before getting them implanted. Associate Health Minister David Seymour . Photo: RNZ / Mark Papalii Some inhalers will also be able to be kept in doctor's and nurses clinics for emergency use, teaching, and demonstrations. Associate Health Minister David Seymour welcomed the moves, saying it was a result of his instruction for Pharmac to start listening to what patients want. "It's been working," he told RNZ. "They've been consulting on a whole lot of things out of my direction to start listening to patients. "Our philosophy is if we can make life easier at no cost, why wouldn't we do it? Easier access to IUDs, better access to asthma inhalers, two obvious win-wins that we can make and really pleased to see this new culture at Pharmac." Seymour said the changes would mean less visits to the pharmacy for resupply, better asthma management, and an extra option for supply in emergencies. "Doctors and nurses will also be able to keep Mirena and Jaydess IUDs in their clinic and will be able to place them in the same appointment. Pharmac will fund these on a PSO to enable this," he said. "Current settings mean women need to get a prescription from their doctor or nurse, pick their IUD up from a pharmacy, and then bring it back to the clinic to be placed. Pharmac estimates over 21,000 women to benefit from these changes in just the first year of funding. "People told Pharmac that these changes will make a real difference. They will make it easier for people with asthma to get the inhalers they need and improve access to long-acting contraceptives like Mirena and Jaydess. They make sense for people." Pharmac's acting director of pharmaceuticals Adrienne Martin said the changes would help over 140,000 New Zealanders in the first year alone. "People have told us that it will remove barriers, reduce delays, and allow for timelier and efficient care." Asthma and Foundation chief executive Letitia Harding said the decision would make a huge difference for Kiwis living with asthma. "When someone is having an asthma attack, they need treatment immediately - there's no time to get a prescription filled," she said. "Patients often need to keep their reliever inhaler in multiple places - at home, school, work, their car - so enhancing access to life-saving asthma medicine will undoubtedly reduce the morbidity of asthma in New Zealand." The change would make asthma management significantly easier, particularly for families facing transport barriers or juggling multiple repeat prescriptions, she said. Sign up for Ngā Pitopito Kōrero , a daily newsletter curated by our editors and delivered straight to your inbox every weekday.
RNZ News
an hour ago
- RNZ News
Want to stop vaping but don't know how? We've got you
science health 16 minutes ago Vaping is often marketed as a tool to ween yourself off smoking - but of course, nicotine vapes are also addictive, so what happens when you want to call it quits altogether? A recent study has surveyed over 1000 Kiwis to better understand why and how people quit vaping. The findings reveal some interesting trends and some great practical tips for quitting. The co-author of the study, Joya Kemper, spoke to Jesse.
RNZ News
an hour ago
- RNZ News
Medsafe makes asthma inhalers, IUDs more accessible
Photo: 123RF Pharmac is making it easier for people to access asthma inhalers and IUD contraception - a move the minister says is sensible and costs no one. From 1 August, people using some strengths of budesonide with eformoterol inhalers for asthma will be available for a three-month prescription instead of just one. Mirena and Jaydess Intra-Uterine Devices (IUDs) - which can prevent pregnancy, including by administering hormones - will be able to be stored at doctors' surgeries. This means patients will not need to pick them up from a pharmacy before getting them implanted. Associate Health Minister David Seymour . Photo: RNZ / Mark Papalii Some inhalers will also be able to be kept in doctor's and nurses clinics for emergency use, teaching, and demonstrations. Associate Health Minister David Seymour welcomed the moves, saying it was a result of his instruction for Pharmac to start listening to what patients want. "It's been working," he told RNZ. "They've been consulting on a whole lot of things out of my direction to start listening to patients. "Our philosophy is if we can make life easier at no cost, why wouldn't we do it? Easier access to IUDs, better access to asthma inhalers, two obvious win-wins that we can make and really pleased to see this new culture at Pharmac." Pharmac's acting director of pharmaceuticals Adrienne Martin said the changes would help over 140,000 New Zealanders in the first year alone. "People have told us that it will remove barriers, reduce delays, and allow for timelier and efficient care." Sign up for Ngā Pitopito Kōrero , a daily newsletter curated by our editors and delivered straight to your inbox every weekday.
